Clinical Significance [fndg]
Lipid [lipd]
Trial [resa]
Reducing [qlco]
Patients [podg]
Diabetes Mellitus, Type 2 [dsyn]
Diabetes Mellitus, Type 2 [dsyn]
Cardiovascular disease [dsyn]
Cardiovascular morbidity [dsyn]
Mortality [qnco]
Current [tmco]
Guidelines [inpr]
Suggest [idcn]
Life Style [socb]
Modification [ftcn]
reduction [npop]
Low density lipoprotein [aapp, bacs, lipd]
Cholesterol [bacs, strd]
Drug Therapy [topp]
Target [ftcn]
mg dl [qnco]
Additional [ftcn]
secondary [neop]
Therapeutic [topp]
Target [ftcn]
Increasing [ftcn]
High Density Lipoprotein Cholesterol [bacs, lipd]
Lower triglycerides [fndg]
Statins [orch, phsu]
First-Line Therapy [topp]
Combination Therapy [topp]
Statins [orch, phsu]
Fibrates [orch, phsu]
Niacin [orch, phsu, vita]
Often [tmco]
Needed [qlco]
Target [ftcn]
Patients [podg]
Diabetes [dsyn]
Statins [orch, phsu]
Decrease [qlco]
Relative Risk [qnco]
Myocardial Infarction [dsyn]
coronary artery disease [dsyn]
Clinical Trials [resa]
High Risk [qlco]
Patients [podg]
With [qlco]
Diabetes [dsyn]
Statins [orch, phsu]
cardiovascular events [fndg]
Fibrates [orch, phsu]
effects [qlco]
High density lipoprotein [aapp, bacs, lipd]
Triglycerides [bacs, lipd]
Glucose tolerance [phsf]
Myocardial Infarction [dsyn]
Limited [ftcn]
Combination [qlco]
Statin [orch, phsu]
Fenofibrate [orch, phsu]
Reduced [qlco]
Reduced [qlco]
Triglycerides [bacs, lipd]
Increased [qnco]
High density lipoprotein [aapp, bacs, lipd]
Compared [acty]
Statin [orch, phsu]
Alone [qnco]
Hope [menp]
ONGOING [idcn]
Trial [resa]
Benefit [qnco]
Combination Therapy [topp]
Patients [podg]
Diabetes [dsyn]
Reserve [acty]
